Earnings Per Share, Basic of ImmunoGen, Inc. from 31 Dec 2019 to 30 Sep 2023
- Taxonomy & unit
- us-gaap: USD/shares
- Description
- The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
- Summary
-
ImmunoGen, Inc. quarterly and annual Earnings Per Share, Basic in USD/shares history and change rate from 31 Dec 2019 to 30 Sep 2023.
- ImmunoGen, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2023 was 0.1.
- ImmunoGen, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2023 was 0, a 63% increase year-over-year.
- ImmunoGen, Inc. annual Earnings Per Share, Basic for 2022 was -0.88, a 29% decline from 2021.
- ImmunoGen, Inc. annual Earnings Per Share, Basic for 2021 was -0.68, a 172% decline from 2020.
- ImmunoGen, Inc. annual Earnings Per Share, Basic for 2020 was -0.25, a 64% increase from 2019.
- Source SEC data
- View on sec.gov
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)
ImmunoGen, Inc. Quarterly Earnings Per Share, Basic (USD/shares)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 2023 | 0 | 0.1 | +0.41 | 01 Jul 2023 | 30 Sep 2023 | 10-Q | 02 Nov 2023 | 2023 | Q3 | |
| Q2 2023 | -1 | -0.02 | +0.22 | +92% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 31 Jul 2023 | 2023 | Q2 |
| Q1 2023 | -1 | -0.16 | -0.06 | -60% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 28 Apr 2023 | 2023 | Q1 |
| Q4 2022 | -1 | -0.23 | -0.05 | -28% | 01 Oct 2022 | 31 Dec 2022 | 10-K | 01 Mar 2023 | 2022 | FY |
| Q3 2022 | -1 | -0.31 | -0.13 | -72% | 01 Jul 2022 | 30 Sep 2022 | 10-Q | 02 Nov 2023 | 2023 | Q3 |
| Q2 2022 | -1 | -0.24 | -0.09 | -60% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 31 Jul 2023 | 2023 | Q2 |
| Q1 2022 | -1 | -0.1 | +0.07 | +41% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 28 Apr 2023 | 2023 | Q1 |
| Q4 2021 | -1 | -0.18 | 01 Oct 2021 | 31 Dec 2021 | 10-K | 01 Mar 2023 | 2022 | FY | ||
| Q3 2021 | -0.18 | 01 Jul 2021 | 30 Sep 2021 | 10-Q | 04 Nov 2022 | 2022 | Q3 | |||
| Q2 2021 | -0.15 | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 01 Aug 2022 | 2022 | Q2 | |||
| Q1 2021 | -0.17 | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 06 May 2022 | 2022 | Q1 |
ImmunoGen, Inc. Annual Earnings Per Share, Basic (USD/shares)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2022 | -0.88 | -0.2 | -29% | 01 Jan 2022 | 31 Dec 2022 | 10-K | 01 Mar 2023 | 2022 | FY |
| 2021 | -0.68 | -0.43 | -172% | 01 Jan 2021 | 31 Dec 2021 | 10-K | 01 Mar 2023 | 2022 | FY |
| 2020 | -0.25 | +0.45 | +64% | 01 Jan 2020 | 31 Dec 2020 | 10-K | 01 Mar 2023 | 2022 | FY |
| 2019 | -0.7 | 01 Jan 2019 | 31 Dec 2019 | 10-K | 28 Feb 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.